Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investing can be risky as stocks may lose momentum when their valuations exceed future growth potential [1] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, identified through the Zacks Momentum Style Score [2] Group 2: MariMed Inc. (MRMD) Analysis - MariMed Inc. (MRMD) has shown a significant price increase of 34.9% over the past four weeks, indicating growing investor interest [3] - Over the past 12 weeks, MRMD's stock gained 69.7%, demonstrating its ability to deliver positive returns over a longer timeframe [4] - MRMD has a high beta of 3.02, suggesting it moves 202% higher than the market in either direction, indicating fast-paced momentum [4] - The stock has a Momentum Score of A, suggesting it is an opportune time to invest [5] - MRMD has a Zacks Rank 1 (Strong Buy) due to upward revisions in earnings estimates, which attract more investors [6] - The stock is trading at a low Price-to-Sales ratio of 0.32, meaning investors pay only 32 cents for each dollar of sales, indicating a reasonable valuation [6] Group 3: Additional Investment Opportunities - Besides MRMD, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [7] - Zacks offers over 45 Premium Screens tailored to different investing styles, aiding in identifying potential winning stocks [8]

Financial Performance - MariMed Inc. reported break-even quarterly earnings per share, surpassing the Zacks Consensus Estimate of a loss of $0.01, representing an earnings surprise of +100.00% [1] - The company posted revenues of $39.61 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 2.91%, compared to year-ago revenues of $40.44 million [2] - Over the last four quarters, MariMed has surpassed consensus EPS estimates two times but has not beaten consensus revenue estimates [2] Stock Performance - MariMed Inc. shares have lost about 9.3% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The current status of estimate revisions translates into a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is -$0.01 on revenues of $42.9 million, and -$0.04 on revenues of $165.38 million for the current fiscal year [7] - The outlook for the industry can significantly impact stock performance, with the Medical - Products industry currently in the bottom 41% of Zacks industries [8]

Core Insights - MariMed Inc. reported financial results for Q2 2025, highlighting growth in operations and revenue, driven by its "Expand the Brand" strategy [1][2] - The company anticipates further growth through new market entries and expanded product distribution [2] Financial Performance - Q2 2025 revenue was $39.6 million, a slight decrease from $40.4 million in Q2 2024 [3] - GAAP gross margin for Q2 2025 was 40%, down from 42% in Q2 2024, while non-GAAP gross margin remained stable at 42% [3] - The company reported a GAAP net loss of $1.3 million for Q2 2025, compared to a loss of $1.6 million in Q2 2024 [3] - Non-GAAP adjusted EBITDA for Q2 2025 was $4.9 million, an increase from $4.4 million in Q2 2024, with an adjusted EBITDA margin of 12% [3] Operational Highlights - The company expanded its product offerings and market presence, including the launch of new products and entry into Pennsylvania [5][9] - MariMed's retail and wholesale revenues showed sequential growth, reflecting strong execution in key markets [2][5] Strategic Initiatives - The management emphasized the importance of brand leverage as a growth engine and highlighted plans for adult-use sales in Delaware and a new licensing agreement in Maine [2][5] - The company is exploring M&A and licensing opportunities, supported by a strong balance sheet [2][5] Cash Flow and Balance Sheet - Cash and cash equivalents at the end of Q2 2025 were $6.1 million, down from $7.3 million at the end of 2024 [19][22] - Total assets decreased to $204.4 million from $207.0 million at the end of 2024, while total liabilities increased to $131.2 million [19][20]

Core Insights - MariMed Inc. has entered a strategic agreement with TILT Holdings to expand the distribution of its medical marijuana products to Pennsylvania [1][2] - Under a Management Services Agreement, MariMed will manage TILT's Standard Farms cultivation and processing facility in Pennsylvania starting September 1, 2025 [2][3] - MariMed will receive a management fee of 12.5% of Standard Farms' gross revenue for its management services [3] Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its award-winning cannabis brands such as Betty's Eddies™, Bubby's Baked™, and Nature's Heritage™ [5] - The company aims to become a leading consumer packaged goods company in the medical marijuana sector through its "Expand the Brand" strategy [4] - TILT Holdings supports cannabis businesses with a diverse portfolio, including technology and cultivation services, and operates in multiple regions including North America and Europe [6] Market Context - Pennsylvania is identified as a strong medical marijuana market and is expected to transition into an adult-use market, presenting growth opportunities for MariMed [4] - The partnership with TILT is seen as a strategic move to leverage existing quality and trust established under the Standard Farms brand to enhance MariMed's market presence [4]

Core Viewpoint - MariMed Inc. has entered a strategic agreement with TILT Holdings to expand the distribution of its medical marijuana products in Pennsylvania, aiming to leverage the state's growing market potential [1][2][4]. Group 1: Strategic Agreement Details - MariMed will manage TILT's Standard Farms cultivation and processing facility in Pennsylvania under a Management Services Agreement (MSA) effective September 1, 2025 [2]. - The MSA has an initial term of four years, with MariMed receiving a management fee of 12.5% of Standard Farms' gross revenue [3]. Group 2: Market Expansion and Strategy - The partnership aligns with MariMed's "Expand the Brand" strategy, focusing on becoming a leading consumer packaged goods company in the medical marijuana sector [4]. - Pennsylvania is identified as a strong medical marijuana market with potential for future adult-use cannabis legalization, presenting significant growth opportunities for MariMed [4]. Group 3: Company Profiles - MariMed is recognized for its award-winning cannabis brands, including Betty's Eddies™, Bubby's Baked™, and others, and is committed to quality and innovation in the cannabis industry [5]. - TILT Holdings supports cannabis businesses through a diverse portfolio, including technology and cultivation services, and operates multiple facilities across North America and Europe [6].

Core Insights - MariMed Inc. has entered a licensing agreement with The Stoned Moose, a cannabis operator in Maine, to expand the distribution of its Betty's Eddies™ full-spectrum fruit chews in the $455 million Maine cannabis market [1][2] - The new agreement allows for the distribution of Betty's Eddies to both adult-use and medical cannabis consumers, with medical cannabis sales accounting for over 50% of Maine's cannabis revenues in 2024 [2] - The CEO of MariMed expressed optimism about the brand's potential in Maine, citing its market leadership in Massachusetts, Maryland, and Delaware, and emphasizing the company's "Expand the Brand" strategy [3] Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, specializing in the development and management of cultivation, production, and retail facilities [4] - The company boasts a portfolio of award-winning cannabis brands, including Betty's Eddies™, Bubby's Baked™, Vibations™, InHouse™, and Nature's Heritage™, which are well-regarded by consumers nationwide [4]

Core Insights - MariMed Inc. has entered into a licensing agreement with The Stoned Moose, a cannabis operator in Maine, to expand the distribution of its Betty's Eddies™ full-spectrum fruit chews in the state's $455 million cannabis market [1][2][3] - The new agreement allows for the distribution of Betty's Eddies to both adult-use and medical cannabis consumers, tapping into a market where medical cannabis sales accounted for over 50% of Maine's cannabis revenues in 2024 [2][3] - The CEO of MariMed expressed optimism about the brand's potential in Maine, citing its market leadership in Massachusetts, Maryland, and Delaware, and positioning this move as part of the company's "Expand the Brand" strategy [3] Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, specializing in the development and management of cultivation, production, and retail facilities [4] - The company boasts a portfolio of award-winning cannabis brands, including Betty's Eddies™, Bubby's Baked™, Vibations™, InHouse™, and Nature's Heritage™, which are well-regarded by consumers across the country [4]

Core Insights - MariMed Inc. has entered a licensing agreement with The Stoned Moose, a cannabis operator in Maine, to expand the distribution of its Betty's Eddies™ full-spectrum fruit chews in the $455 million Maine cannabis market [1][2] - The new agreement allows for the distribution of Betty's Eddies to both adult-use and medical cannabis consumers, with medical cannabis sales accounting for over 50% of Maine's cannabis revenues in 2024 [2] - The CEO of MariMed expressed optimism about the brand's potential in Maine, citing its market leadership in edibles in Massachusetts, Maryland, and Delaware, and aligning with the company's "Expand the Brand" strategy [3] Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, focusing on the development and management of advanced cultivation, production, and retail facilities [4] - The company boasts a portfolio of award-winning cannabis brands, including Betty's Eddies™, Bubby's Baked™, and others, which are well-regarded by consumers across the United States [4] Industry Context - The cannabis market in Maine is valued at $455 million, indicating significant growth potential for companies like MariMed that are expanding their product offerings [1] - Medical cannabis sales are a crucial segment of the market, representing more than half of the total cannabis revenues in the state [2]

Core Insights - MariMed Inc. has entered into a licensing agreement with The Stoned Moose, a vertically integrated cannabis operator in Maine, to expand the distribution of its Betty's Eddies™ full-spectrum fruit chews in the $455 million Maine cannabis market [1][2] - The new agreement allows for the distribution of Betty's Eddies to both adult-use and medical cannabis consumers, with medical cannabis sales accounting for over 50% of Maine's cannabis revenues in 2024 [2] - The CEO of MariMed expressed optimism about the brand's potential in Maine, citing its market leadership in edibles in Massachusetts, Maryland, and Delaware, and viewing this partnership as a strategic step in their "Expand the Brand" strategy [3] Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, specializing in the development and management of advanced cultivation, production, and retail facilities [4] - The company boasts a portfolio of award-winning cannabis brands, including Betty's Eddies™, Bubby's Baked™, Vibations™, InHouse™, and Nature's Heritage™, which are well-regarded by consumers nationwide [4]

Core Viewpoint - MariMed Inc. is set to report its second quarter 2025 financial results on August 6, 2025, with a conference call scheduled for August 7, 2025, to discuss these results [1][2]. Company Overview - MariMed Inc. is a leading multi-state cannabis operator, recognized for its advanced cultivation, production, and retail facilities [3]. - The company boasts an award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby's Baked™, InHouse™, Nature's Heritage™, and Vibations™, which are well-regarded by consumers nationwide [3]. - MariMed is committed to excellence and aims to drive growth while setting new standards in the cannabis industry [3].